We subsequently confirmed their modulation at the protein level by immunohistochemistry (Figure 4A and 4B): cytoplasmic staining of CRABP1 was increased in follicular adenoma, and FABP4 expression was reduced in adenoma and further reduced in carcinoma. The gene discussed is CRABP1; the disease is carcinoma.